• News
  • Video
  • Prices
  • Research
  • Events
  • Data & Indices
  • More
  • Sponsored
    Sign In
    Sign Up
Loading chart...


About
  • About Us
  • Masthead
  • Careers
  • Blog
  • Investor Relations
Contact
  • Contact Us
  • Accessibility
  • Advertise
  • Media Kit
  • Sitemap
  • System status
Newsletters
  • CoinDesk Headlines
  • Crypto Daybook Americas
  • State of Crypto
  • Crypto for Advisors
  • Crypto Long & Short
News
  • Markets
  • Finance
  • Tech
  • Policy
  • Focus
Videos
  • CoinDesk Daily
  • Editor's Picks
  • Shorts
  • Spotlight
Podcasts
  • CoinDesk Podcast Network
  • Markets Outlook
  • Gen C
Cryptocurrencies
  • Latest crypto prices
  • Trending
  • Bitcoin (BTC)
  • Ethereum (ETH)
  • Hyperliquid (HYPE)
  • XRP
  • Solana (SOL)
Data & Indices
  • Market Data
  • Index Offering
  • API
  • Research Insights
  • Documentation and Governance
Events
  • CoinDesk: Policy & Regulation
  • Webinars
Sponsored
  • Thought Leadership
  • Press Releases
  • Advertise with CoinDesk
Research
  • Research Hub
  • Exchange Benchmark

EthicsPrivacyTerms of UseCookie SettingsDo Not Sell My InfoBug Bounty Program
X icon
© 2026 CoinDesk, Inc.

Disclosure & Polices: CoinDesk is an award-winning media outlet that covers the cryptocurrency industry. Its journalists abide by a strict set of editorial policies. CoinDesk has adopted a set of principles aimed at ensuring the integrity, editorial independence and freedom from bias of its publications. CoinDesk is part of Bullish (NYSE:BLSH), an institutionally focused global digital asset platform that provides market infrastructure and information services. Bullish owns and invests in digital asset businesses and digital assets and CoinDesk employees, including journalists, may receive Bullish equity-based compensation.

CD20$2,139.75CD20 down 0.10 percent0.10%BTC$77,131.14BTC down 0.15 percent0.15%ETH$2,384.60ETH down 1.16 percent1.16%XRP$1.35XRP up 0.028 percent0.028%SOL$99.43SOL down 0.22 percent0.22%
Prices > PFE
PFEPFE
$28.96Up 1.44 percent, +$0.411.44%($0.41)
As of today at 12:58 PM ET

Key Stats

Market Cap$162.726B
Volume (24h)18,285,472
Day's Range$28.57-$29.08
52-Week Range$23.58-$29.09
PE Ratio--
EPS-0.04
Net Income (FY)$7.81B
Revenue (FY)$62.58B

About Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Website
pfizer.com
Industry
PHARMACEUTICAL PREPARATIONS
Full-time Employees
75,000
Headquarters
NEW YORK
IPO Date
Jun 22, 1951
Loading chart...
24 hours5 days1 monthYTD1 yearAll time
Up 1.44 percent1.44%
Up 3.35 percent3.35%
Up 15.79 percent15.79%
Up 15.89 percent15.89%
Up 16.96 percent16.96%
—

Similar Stocks

S
S&P 500 ETFSPY
$764.79
Up 0.40 percent0.40%($3.01)
BullishBLSH
$32.61
Down 1.36 percent1.36%($0.45)
Coinbase Global IncCOIN
$174.88
Down 1.10 percent1.10%($1.94)
Circle Internet GroupCRCL
$88.85
Down 0.70 percent0.70%($0.63)

Pinakabago PFE Balita

2 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now
5 oras ang nakalipasPositibo
(opens in a new tab)

2 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now

Araw bago ang kahaponPositibo(opens in a new tab)

From Padcev to PF-08634404: Pfizer's Oncology Growth Push

5 araw ang nakalipasPositibo(opens in a new tab)

Breast Cancer Therapeutics Market Size to Reach USD 95.14 Billion at a CAGR of 9.20% from 2035 – SNS Insider

6 (na) araw ang nakalipasNeutral(opens in a new tab)

Can Eli Lilly's Oncology Portfolio Drive Growth Beyond GLP-1 Drugs?

7 araw ang nakalipasNeutral(opens in a new tab)

$7+ Billion mRNA Vaccines Market Outlook, 2035: Opportunities, Strategies, Challenges

8 araw ang nakalipasPositibo(opens in a new tab)

AI Poised to Reshape Blood Cancer Therapeutics as Investment Surges Past $2 Billion Across Leading Biotech and Pharma Players

8 araw ang nakalipasNeutral(opens in a new tab)

State of the Life Sciences Industry to Be Reviewed in BCC Research's 2026 Second Quarter Outlook, Spotlighting AI-Driven Discovery, Precision Oncology, and Connected Health Adoption